Alphamab Oncology is a biopharmaceutical company based in China that develops medicines for cancer. It works on antibody-based treatments, including bispecific antibodies and antibody-drug conjugates, which are designed to target tumours through the body's immune system and through directed drug delivery. Its pipeline covers a range of solid tumours and blood cancers, and the company carries out research, clinical development and manufacturing of these therapeutic candidates for patients and healthcare providers.
On this site Alphamab Oncology appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 9966, with prices in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1506 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendWeak
44/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-15.4%
From 52-week high-49.5%
MomentumWeak
33/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-4.1%
6-month return-36.2%
12-month, skipping last month-40.7%
Stability (higher is calmer)Weak
43/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)59.6%
Worst drawdown, 1 year (smaller is calmer)-54.4%
LiquidityStrong
75/100
Trades actively.
See the numbers →
Avg daily value traded9.54M HKD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 6.230 – 15.680Daily closes, split-adjusted
Signals
50-day average8.090
200-day average8.590
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.406
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
7.20
Bullish
EMA 10
7.26
Bullish
SMA 20
7.75
Bearish
EMA 20
7.55
Bearish
SMA 50
8.09
Bearish
EMA 50
7.85
Bearish
SMA 100
7.76
Bearish
EMA 100
8.09
Bearish
SMA 200
8.59
Bearish
EMA 200
8.40
Bearish
Oscillators (daily)
RSI (14)
42.49
Neutral
MACD (12, 26)
-0.32
Bearish
Momentum (12)
-12.46
Bearish
Stochastic %K (14)
32.26
Neutral
Williams %R (14)
-67.74
Neutral
CCI (20)
-63.77
Neutral
Pivot points (classic, last session)
S3
6.68
S2
6.84
S1
7.06
Pivot
7.22
R1
7.43
R2
7.59
R3
7.81
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
